Mapmygenome Completes Acquisition of dnaPower

Mapmygenome Acquires Microbiome Insights

May 29, 2025

Biotechnology

Mapmygenome, an AI-driven genomics company based in Hyderabad, India, has acquired Microbiome Insights, a Canadian microbiome sequencing and bioinformatics CRO with a CAP-accredited lab. The deal expands Mapmygenome's capabilities in metagenomics and bioinformatics and accelerates its geographic expansion into North America; financial terms were not disclosed.

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

Genetic Technologies Acquires AffinityDNA Direct-to-Consumer Business

July 14, 2022

Biotechnology

Genetic Technologies Limited (GENE) completed the acquisition of the direct-to-consumer eCommerce business and distribution rights of AffinityDNA, including websites, brand identities, laboratory testing and distribution agreements. The deal expands GENE’s direct-to-consumer channel and product portfolio across the US, UK and Europe, adding AffinityDNA’s consumer and pet genomics offerings to GENE’s geneType and EasyDNA brands.

AMP Agency Acquires Genome

May 24, 2022

Marketing & Advertising

AMP Agency, a full-service digital marketing agency and part of Advantage Solutions, has acquired Genome, an award-winning digital innovation and product development company. The acquisition strengthens AMP Agency's technology and product capabilities and supports its strategy to scale technology-enabled innovation and expand internationally; Genome's leadership will join AMP in senior technology roles.

Genome Medical Acquires GeneMatters

August 30, 2021

Healthcare Services

Genome Medical, a South San Francisco–based genomic care delivery company, will acquire GeneMatters, a telehealth genetic counseling and software solutions provider. The deal coincides with Genome Medical's closing of a $60 million Series C financing led by Casdin Capital to accelerate commercial growth and expand technology-enabled genetic services.

Igenomix Acquires Access Genomics Canada from Persistence Capital Partners

December 14, 2020

Biotechnology

Igenomix, a Spanish reproductive-genetics company, acquired Toronto-based laboratory Access Genomics (Access Genomics Canada) from Persistence Capital Partners on December 14, 2020. The acquisition expands Igenomix’s presence in North America and strengthens its ability to serve fertility clinics in the Toronto area.